Molecular Approaches for the Treatment of Pompe Disease.

Abstract excerpt

Glycogen storage disease type II (GSDII, Pompe disease) is a rare metabolic disorder caused by a deficiency of acid alpha-glucosidase (GAA), an enzyme localized within lysosomes that is solely responsible for glycogen degradation in this compartment. The manifestations of GSDII are heterogeneous but are classified as early or late onset. The natural course of early-onset Pompe disease (EOPD) is severe and rapidly...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to alpha-Glucosidases
• Share to Glycogen
• Share to Glycogen Storage Disease Type II